Virus
Influenza B Virus
FLUBV
Strain/Type
Genus: influenza virus within the family of Orthomyxoviridae
Host tropism
Humans and marine mammals (seals).
This biological agent is host-dependent parasitical.
Route of Transmission
Transmission takes place via inhalation (by breathe).
Transmission takes place orally (by ingestion).
Zoonosis (transmission between animals and humans): Yes
Characteristics e.g. sensitizing or toxic effects, replication deficiant, not infectious, attenuated, inactivated (upload relevant documents)
Facultative human-pathogenic (it does not necessarily cause diseases in humans).
Note V:
Effective vaccine available. The "V" tag has been adopted from Annex III of Directive 2000/54/EC.
Approved as biological safety measure if taken as recipient organism for genetic engineering?
Genetically modified (GenTSV)
Risk group (BioStoffV)
2
Risk assessment
Risk accessment based on TRBA (Technical Rule for Biological Agents) 462 "Classification of viruses into risk groups": https://www.baua.de/DE/Angebote/Rechtstexte-und-Technische-Regeln/Regelwerk/TRBA/TRBA-462.html
Operation instructions (mandatory for RG2 and higher)
https://biostoffe.dguv.de/data?name=830677&lang=en
Occupational health care (according to ArbMedVV)
Mandatory health care:
In the case of tasks specifically involving contact with the biological agent, an health care must be provided by the employer before commencement and then at regular intervals.
In the case of tasks involving incidental contact with the biological agent in research facilities or laboratories where regular activities which involve the possibility of coming into contact with infected or suspected samples, with infected or suspected animals, or objects or materials containing or contaminated with pathogens are carried out, the employer must provide an health care.
When finishing an activity for which mandatory health care had to be occasioned, the employer must offer optional health care.
An optional health care must also be offered if as a result of the exposure to biological agents
- a serious infectious illness is to be expected and post-exposure prophylatic measures are possible,
or
- an infection has resulted.
Vaccination:
A vaccine is available.
Storage location of aliquots in the Biolab (just click Bearbeiten in the right corner of the header to add or change information in the table and use the menue in the left header to e.g. add a row)
source | virus strain | freezing date | virus amount per vial | stock was produced on | no. of aliquots | belongs to (full name) | rack/box in N2 tank or -80°C freezer and location (room, address) | comments |
---|---|---|---|---|---|---|---|---|